Cargando…

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease

INTRODUCTION: The purpose of this study was to determine whether anti-tumour necrosis factor alpha (anti-TNF-α) antibody, infliximab, can inhibit T helper 17 (Th17) differentiation in uveitis patients who have Behçet's disease (BD). METHODS: To measure inflammatory cytokines, ocular fluid sampl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugita, Sunao, Kawazoe, Yuko, Imai, Ayano, Yamada, Yukiko, Horie, Shintaro, Mochizuki, Manabu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446476/ https://www.ncbi.nlm.nih.gov/pubmed/22546542 http://dx.doi.org/10.1186/ar3824

Ejemplares similares

A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
por: Horiguchi, Noe, et al.
Publicado: (2020)

Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
por: Ono, Takashi, et al.
Publicado: (2020)

Behçet's Uveitis
por: Tugal-Tutkun, Ilknur
Publicado: (2009)

Behçet’s Disease Uveitis
por: Joubert, Morgane, et al.
Publicado: (2023)

Comprehensive analysis of vitreous specimens for uveitis classification: a prospective multicentre observational study
por: Maruyama, Kazuichi, et al.
Publicado: (2017)

Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients
por: Lee, Ji Hwan, et al.
Publicado: (2018)

TNF and anti-TNF agents in Behçet's disease
por: Calamia, KT
Publicado: (2003)

Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet's Disease, Sarcoidosis, and Noninfectious Uveitis
por: Sánchez-Cano, Daniel, et al.
Publicado: (2013)

Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet’s disease in Taiwan
por: Hu, Ya-Chiao, et al.
Publicado: (2019)

Macular involvement in patients with Behçet’s uveitis
por: Kahloun, Rim, et al.
Publicado: (2012)

Vitreomacular Interface Disorders in Behçet’s Uveitis
por: Eser Öztürk, Hilal, et al.
Publicado: (2017)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

Risk Factors Leading to Anti-TNF Alpha Therapies in Pediatric Severe Uveitis
por: Osswald, Delphine, et al.
Publicado: (2022)

Resuming anti-TNF therapy after development of miliary tuberculosis in Behcet’s disease-related uveitis: a case report
por: Toriu, Chika, et al.
Publicado: (2023)

Immune Privilege and Eye-Derived T-Regulatory Cells
por: Keino, Hiroshi, et al.
Publicado: (2018)

Bell’s palsy during interferon alpha 2a treatment in a case with Behçet uveitis
por: Yalçindağ, Fatime Nilüfer, et al.
Publicado: (2013)

Gender Differences in Behçet's Disease Associated Uveitis
por: Ucar-Comlekoglu, Didar, et al.
Publicado: (2014)

Behçet’s Uveitis: Current Diagnostic and Therapeutic Approach
por: Çakar Özdal, Pınar
Publicado: (2020)

Behçet uveitis: Current practice and future perspectives
por: Aboul Naga, Shereen H., et al.
Publicado: (2022)

How challenging can it be to treat Behçet uveitis?
por: Oray, Merih, et al.
Publicado: (2022)

Commentary: Behçet’s uveitis – Expanding treatment horizons
por: Moreker, Mayur R
Publicado: (2023)

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis
por: Yalçındağ, F. Nilüfer, et al.
Publicado: (2021)

The Role of Th17 Cells in the Pathogenesis of Behcet’s Disease
por: Nanke, Yuki, et al.
Publicado: (2017)

HTLV-1 uveitis
por: Kamoi, Koju, et al.
Publicado: (2012)

Association between subfoveal choroidal thickness and leakage site on fluorescein angiography in Behçet’s uveitis
por: Shirahama, Shintaro, et al.
Publicado: (2019)

Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody
por: Sugita, Sunao, et al.
Publicado: (2017)

P03-009 - Experiences of in pediatric Behçet uveitis
por: Sozeri, B, et al.
Publicado: (2013)

Pattern of Uveitis Associated with Behçet’s Disease in an Egyptian Cohort
por: Abd El Latif, Eiman, et al.
Publicado: (2020)

Old and New Challenges in Uveitis Associated with Behçet’s Disease
por: Gueudry, Julie, et al.
Publicado: (2021)

Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease
por: Emmi, Giacomo, et al.
Publicado: (2016)

Enhancement of Th1/Th17 inflammation by TRIM21 in Behçet’s disease
por: Ahn, Yuri, et al.
Publicado: (2017)

Aortitis and uveitis. A challenging case of Takayasu or Behcet disease?
por: Di Landro, Giancarla, et al.
Publicado: (2014)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
por: Hiyama, Tomona, et al.
Publicado: (2019)

Pattern and Visual Prognostic Factors of Behcet’s Uveitis in Northwest Iran
por: Alizadeh Ghavidel, Leila, et al.
Publicado: (2022)

A novel mechanism of macular holes in patients with Behçet's uveitis
por: Alsarhani, Waleed K., et al.
Publicado: (2022)

Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis
por: Guo, Kailei, et al.
Publicado: (2021)

Expression of Th-17 and RORγt mRNA in Behçet’s Disease
por: Hamzaoui, Kamel, et al.
Publicado: (2011)

Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis
por: Hu, Yunwei, et al.
Publicado: (2020)

Uveitis developing in tuberculous lymphadenitis‐associated Behçet's disease during anti‐tuberculosis therapy
por: Takahashi, Saeko, et al.
Publicado: (2020)

Biological Treatments in Behçet's Disease: Beyond Anti-TNF Therapy
por: Caso, Francesco, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0ehvvmpksn4kqb57b90vn9o363